Wearable Cardioverter Defibrillators Market Size

  • Report ID: 874
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Wearable Cardioverter Defibrillators Market Outlook:

Wearable Cardioverter Defibrillators Market size was valued at USD 274.58 million in 2025 and is likely to cross USD 680.47 million by 2035, registering more than 9.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of wearable cardioverter defibrillators is assessed at USD 298.06 million.

The reason behind the growth is due to the rising incidence of cardiovascular diseases across the globe. Cardiovascular disease deaths have increased by more than 55% worldwide in the past 30 years.

Diabetes-related high blood sugar levels can harm the nerves that control the heart and blood vessels, resulting in a variety of cardiovascular diseases such as coronary artery disease, which affects the electrical conduction system in the heart, causing ventricular arrhythmias and atrial fibrillation. This increases the demand for common cardiac disease and rhythm monitoring, which is likely to boost market growth. 

The growing technological advancement in cardiology are believed to fuel the market growth. For instance, artificial intelligence (AI) components are already being utilized in radiology and cardiology's backends including wearable cardiac monitoring devices and point-of-care (POC) triage apps that are being utilized with wearables or smartphone-based apps that record ECG to automatically detect arrhythmias and notify patients.


Wearable Cardioverter Defibrillators

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of wearable cardioverter defibrillators is assessed at USD 298.06 million.

The global wearable cardioverter defibrillators market size crossed USD 274.58 million in 2025 and is likely to register a CAGR of over 9.5%, exceeding USD 680.47 million revenue by 2035.

By 2035, North America is anticipated to command a 38% share of the wearable cardioverter defibrillators market, supported by expanded R&D capabilities and increasing healthcare expenditure owing to advanced device innovation.

Key players in the market include ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos